Efficacy and safety of L-ornithine L-aspartate combined with lactulose in treatment of hepatic encephalopathy: a systematic review and meta-analysis of randomized controlled trial
BackgroundHepatic encephalopathy (HE) represents a collection of metabolic disturbances and regulatory imbalances within the central nervous system that result from advanced liver conditions.PurposeThis article explores the efficacy and safety evaluation of L-ornithine L-aspartate (LOLA) combined wi...
Saved in:
| Main Authors: | Hui Zhang, Yujuan Fu, Minghao Lin, Zheng Nan, Dexi Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1581792/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Results of using L-ornitin-L-aspartate in the treatment of hepatic encephalopathy in liver transplantation
by: S. E. Voskanyan, et al.
Published: (2021-09-01) -
L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A
by: Nourhane Obeid, et al.
Published: (2023-03-01) -
Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)
by: M. Yu. Nadinskaia, et al.
Published: (2024-03-01) -
HYPERAMMONIUM IN PATIENTS WITH PRECIRRHOSIS STAGE: CLINICAL REALITY?
by: L. Yu. Ilchenko, et al.
Published: (2018-06-01) -
EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
by: L. Yu. Ilchenko, et al.
Published: (2016-10-01)